Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review. (2024)

First Author: Gape PMD
Attributed to:  Development of novel acyclic chelators for gallium-68 and scandium-44 used in PET funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ph17030334

PubMed Identifier: 38543120

Publication URI: http://europepmc.org/abstract/MED/38543120

Type: Journal Article/Review

Volume: 17

Parent Publication: Pharmaceuticals (Basel, Switzerland)

Issue: 3

ISSN: 1424-8247